Resonate Bio Awarded the Austria Wirtschaftsservice’s DeepTech Pre-Seed Grant to Accelerate AI-NMR Innovation
Resonate Bio, an emerging Austrian biotech startup, is thrilled to announce it has been awarded the prestigious DeepTech Pre-Seed Grant from the Austria Business Service (AWS) – Austria’s federal business agency.
This grant serves as a catalyst for Resonate Bio’s mission to transform drug discovery using its pioneering hybrid AI-NMR technology. By capturing dynamic, movie-like ensembles of drug candidates bound to proteins, Resonate Bio enables structure-based drug design for disease-causing proteins previously considered undruggable due to their high flexibility.
Unlike traditional static imaging methods, Resonate Bio’s technology fuses advanced AI algorithms with high-resolution solution-phase NMR data to produce Resonate Structures – dynamic representations of drug-protein interactions. With AWS backing, the company will scale its operations, boost its research pipeline, and pursue strategic collaborations that unlock new therapeutic possibilities..